1. 1.Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Annals of Pharmacotherapy 2007; 41(12): 1992-2001.## [DOI:10.1345/aph.1K302] [PMID]

2. 2.Fleitas PE, Travacio M, Martí-Soler H, Socías ME, Lopez WR, Krolewiecki AJ. The strongyloides stercoralis-hookworms association as a path to the estimation of the global burden of strongyloidiasis: A systematic review. PLoS Neglected Tropical Diseases 2020; 14(4): e0008184.## [DOI:10.1371/journal.pntd.0008184] [PMID] []

3. 3.Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 2013; 7(7): e2288.## [DOI:10.1371/journal.pntd.0002288] [PMID] []

4. 4.Farthing M, Albonico M, Bisoffi Z, Bundy D, Buonfrate D, Chiodini P, et al. World gastroenterology organisation global guidelines: management of strongyloidiasis february 2018-compact version. Journal of Clinical Gastroenterology 2020; 54(9): 747-57.## [DOI:10.1097/MCG.0000000000001369] [PMID]

5. 5.Johnston FH, Morris PS, Speare R, McCarthy J, Currie B, Ewald D, et al. Strongyloidiasis: a review of the evidence for Australian practitioners. Australian Journal of Rural Health 2005; 13(4): 247-54.## [DOI:10.1111/j.1440-1584.2005.00710.x] [PMID]

6. 6.Eslahi AV, Badri M, Nahavandi KH, Houshmand E, Dalvand S, Riahi SM, et al. Prevalence of strongyloidiasis in the general population of the world: a systematic review and meta-analysis. Pathog Glob Health 2021; 115(1): 7-20.## [DOI:10.1080/20477724.2020.1851922] [PMID] []

7. 7.Eslahi AV, Olfatifar M, Houshmand E, Johkool MG, Zibaei M, Foroutan M, et al. Prevalence of Strongyloides stercoralis in the immunocompetent and immunocompromised individuals in Iran: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg 2022; 116(2): 87-99.## [DOI:10.1093/trstmh/trab104] [PMID]

8. 8.Czeresnia JM, Weiss LM. Strongyloides stercoralis. Lung 2022; 200(2): 141-8.## [DOI:10.1007/s00408-022-00528-z] [PMID] []

9. 9.Agrawal V, Agarwala T, Ghoshalb UC. Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics. Trans R Soc Trop Med Hyg 2009; 103(3): 242-6.## [DOI:10.1016/j.trstmh.2008.08.009] [PMID]

10. 10.Vaiyavatjamai P, Boitano JJ, Techasintana P, Tungtrongchitr A. Immunocompromised group differences in the presentation of intestinal strongyloidiasis. Jpn J Infect Dis 2008; 61(1): 5-8.## [DOI:10.7883/yoken.JJID.2008.5] [PMID]

11. 11.Newberry AM, Williams DN, Stauffer WM, Boulware DR, Hendel-Paterson BR, Walker PF. Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 2005; 128(5): 3681-4.## [DOI:10.1378/chest.128.5.3681] [PMID] []

12. 12.Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Current Opinion in Infectious Diseases 2010; 23(5): 500.## [DOI:10.1097/QCO.0b013e32833df718] [PMID] []

13. 13.Buonfrate D, Perandin F, Formenti F, Bisoffi Z. A retrospective study comparing agar plate culture, indirect immunofluorescence and real-time PCR for the diagnosis of Strongyloides stercoralis infection. Parasitology 2017; 144(6): 812.## [DOI:10.1017/S0031182016002559] [PMID]

14. 14. 1. Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg. 1999;60(1):146-9.## [DOI:10.4269/ajtmh.1999.60.146] [PMID]

15. 15.Declan J. Bolton, Lucy J. Robertson, mental health disorders associated with foodborne pathogens. Journal of Food Protection 2016; 79(11): 2005-17.## [DOI:10.4315/0362-028X.JFP-15-587] [PMID]

16. 16.Esmaeli S, Fakhar M, Gohardehi S, Janbabaei Q, Ahmadpour E, Bastani R. Strongyloides stercoralis infection: neglected parasitic infection among cancer patients. Pars Journal of Medical Sciences 2022; 10(4): 13-8.## [DOI:10.29252/jmj.10.4.13]

17. 17.Ahmadi NA, Gachkar L, Pakdad K, Ahmadi O. Ability of formalin-ether, wet mount and formalin-acetone methods in diagnosing intestinal parasitic infections. Iranian Journal of Infectious Diseases and Tropical Medicine[Internet] 2016; 12(38): 43-7. ##

18. 18.Khanna V, Tilak K, Prakash PY, Mukhopadhyay C. Modified agar plate culture method for culture of Strongyloides stercoralis. Tropical Parasitology 2015; 5(2): 136-8.## [DOI:10.4103/2229-5070.162535] [PMID] []

19. 19.Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clinical Microbiology Reviews 2004; 17(1): 208-17.## [DOI:10.1128/CMR.17.1.208-217.2004] [PMID] []

20. 20.Tork M, Sharif M, Yazdani Charati J, Nazar I, Hosseini SA. Prevalence of intestinal parasitic infections and associated risk factors in west of mazandaran province, Iran. J Mazandaran Univ Med Sci 2016; 25(134): 81-8.##

21. 21.Sardaryan KH. Investigation of the prevalence of intestinal parasites along with clinical signs and symptoms in patients referred to health centers in Hamedan during 1377-78. Ibn Sina Journal of Clinical Medicine(Scientific Journal of Hamedan University of Medical Sciences and Health Services)[Internet] 1379; 7(4 (series 18)): 49-53. ##

22. 22.Monsef A, Hashemi S, Abbasi M, Taherkhani HA, Shalchi Z, Eliasi A. Prevalence of intestinal parasites in patients with malignancy in the oncology department of Sina Hospital in Hamadan. Journal of Gorgan University of Medical Sciences 2016; 9: 4.##

23. 23.Ahmadi M, Beigom Kia E, Rezaeian M, Hosseini M, Kamranrashani B, Tarighi F. Prevalence of Strongyloides stercoralis and other intestinal parasites in rehabilitation centers in Mazandaran Province, Northern Iran. Journal of Mazandaran University of Medical Sciences 2015; 25(130): 1-7.##

24. 24.Mohammadi-Meskin V, Hamedi Y, Heydari-Hengami M, Eftekhar E, Shamseddin J, Sharifi-Sarasiabi K. Intestinal parasitic infections in mental retardation center of bandar abbas, southern Iran. Iranian Journal of Parasitology 2019; 14(2): 318.## [DOI:10.18502/ijpa.v14i2.1145] [PMID] []

25. 25.Saeidinia A, Tavakoli I, Naghipour MR, Rahmati B, Lahiji HG, Salkhori O, et al. Prevalence of Strongyloides stercoralis and other intestinal parasites among institutionalized mentally disabled individuals in Rasht, northern Iran. Iranian Journal of Parasitology 2016; 11(4): 527.##

26. 26.Shokri A, Sarasiabi KS, Teshnizi SH, Mahmoodi H. Prevalence of strongyloides stercoralis and other intestinal parasitic infections among mentally retarded residents in central institution of southern Iran. Asian Pacific Journal of Tropical Biomedicine 2012: 2(2): 88-91.## [DOI:10.1016/S2221-1691(11)60198-6] [PMID]

27. 27.Shehata AI, Hassanein F. Intestinal parasitic infections among mentally handicapped individuals in Alexandria, Egypt. Ann Parasitol 2015; 61(4): 275-81.##

28. 28.Buonfrate D, Bisanzio D, Giorli G, Odermatt P, Fürst T, Greenaway C, et al. The Global Prevalence of Strongyloides stercoralis Infection. Pathogens 2020; 9(6): 50-6.## [DOI:10.3390/pathogens9060468] [PMID] []

29. 29.Teimouri A, Alimi R, Farsi S, Mikaeili F. Intestinal parasitic infections among patients referred to hospitals affiliated to Shiraz University of Medical Sciences, southern Iran: a retrospective study in pre- and post-COVID-19 pandemic. Environmental Science and Pollution Research 2022; 29(24): 36911-9.## [DOI:10.1007/s11356-021-18192-w] [PMID] []

30. 30.Weeks JC, Roberts WM, Leasure C, Suzuki BM, Robinson KJ, Currey H, et al. Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing. Scientific Reports 2018; 8(1): 975.## [DOI:10.1038/s41598-017-18457-w] [PMID] []

31. 31.Lapinskas PJ, Ben-Harari RR. Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. Postgraduate Medicine 2019; 131(8): 589-96.## [DOI:10.1080/00325481.2019.1655258] [PMID]